Daniel Dorgan
Impact in
- Small Animals top 5%
- Infectious Diseases and Mycology
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology
Papers in
-
- Cystic Fibrosis Research Advances 10
- Neonatal Respiratory Health Research 5
-
- Mycobacterium research and diagnosis 4
- Respiratory viral infections research 3
- Co-authors
- Denis Hadjiliadis (9 shared papers)Patrick A. Flume (3 shared papers)David E. Griffith (3 shared papers)Charles L. Daley (3 shared papers)Kevin Winthrop (2 shared papers)Gina Eagle (3 shared papers)Doreen Addrizzo‐Harris (3 shared papers)Stephen J. Ruoss (3 shared papers)
- Journals
- Journal of Cystic Fibrosis (10 papers)International Forum of Allergy & Rhinology (2 papers)Expert Review of Respiratory Medicine (1 paper)Annals of the American Thoracic Society (1 paper)Respiratory Medicine (1 paper)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Daniel Dorgan
19 papers receiving 426 citations
Hit Papers
Peers
Comparison fields: 5 of 69
- Small Animals 75
- Infectious Diseases 162
- Sensory Systems 40
- Pulmonary and Respiratory Medicine 163
- Epidemiology 172
Countries citing papers authored by Daniel Dorgan
This map shows the geographic impact of Daniel Dorgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Dorgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Dorgan more than expected).
Fields of papers citing papers by Daniel Dorgan
This network shows the impact of papers produced by Daniel Dorgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Dorgan. The network helps show where Daniel Dorgan may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Dorgan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 169 | |
| 2 | Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study Hit paper breakdown → | 2023 | 82 |
| 3 | 2015 | 46 | |
| 4 | 2019 | 27 | |
| 5 | 2022 | 22 | |
| 6 | 2020 | 19 | |
| 7 | 2020 | 14 | |
| 8 | 2019 | 9 | |
| 9 | 2023 | 8 | |
| 10 | 2014 | 8 | |
| 11 | 2013 | 7 | |
| 12 | 2020 | 7 | |
| 13 | 2023 | 6 | |
| 14 | 2015 | 5 | |
| 15 | Randomized, Double-Blind, Placebo-Controlled Study and Open-Label Extension of Liposomal Amikacin for Inhalation (LAI) in Patients with Recalcitrant Nontuberculous Mycobacterial Lung Disease (NTM-LD) | 2014 | 3 |
| 16 | 2023 | 2 | |
| 17 | 2021 | 2 | |
| 18 | 2023 | 1 | |
| 19 | 2015 | 1 | |
| 20 | 2024 | 0 |
About Daniel Dorgan
Daniel Dorgan is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology, Infectious Diseases, Organic Chemistry and Surgery, having authored 21 papers that have together received 438 indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (10 papers), Neonatal Respiratory Health Research (5 papers), Tuberculosis Research and Epidemiology (4 papers), Mycobacterium research and diagnosis (4 papers), Quinazolinone synthesis and applications (3 papers), Antifungal resistance and susceptibility (3 papers), Respiratory viral infections research (3 papers) and Asthma and respiratory diseases (2 papers). The work is most often cited by research in Small Animals (75 citations), Infectious Diseases (162 citations), Sensory Systems (40 citations), Pulmonary and Respiratory Medicine (163 citations) and Epidemiology (172 citations). Daniel Dorgan has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Denis Hadjiliadis, Patrick A. Flume, David E. Griffith, Charles L. Daley, Kevin Winthrop, Gina Eagle, Doreen Addrizzo‐Harris, Stephen J. Ruoss, Richard J. Wallace and Matthias Salathé. Their work appears in journals such as Journal of Cystic Fibrosis, International Forum of Allergy & Rhinology, Expert Review of Respiratory Medicine, Annals of the American Thoracic Society and Respiratory Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.